Testing the SUMMIT Brush Together with Ocusoft Lid Scrub to Treat Blepharitis and Improve Eyelid Hygiene

What this Trial Is About

Dry Eye Disease DED affects around 15 to 30 million people in the United States and creates significant social and economic challenges. A major cause of DED is blepharitis, a chronic inflammation of the eyelid margins that can lead to obstruction and loss of glands vital for tear production. Traditional care involves self-administered products like eyelid foams, gels, and pads, but these have limitations and some patients require costly in-office procedures. This research aims to evaluate whether a new disposable ocular brush, used with a common eyelid cleanser, is more effective at removing eyelid debris than the cleanser alone. Participants will be divided into two groups one using the standard treatment of Ocusoft Lid Scrub Original Foaming Eyelid Cleanser once daily, and the other using the same cleanser combined with the experimental Summit Ocular Brush for gentle scrubbing of the eyelids. The brush is disposable and replaced every two weeks. The study includes a treatment period of one month with follow-up visits at two and four weeks. Digital images and videos of the eyelids will be taken to assess debris removal. During the study, participants will complete the SPEED questionnaire and undergo slit lamp exams at each visit to evaluate blepharitis severity. The research team will analyze counts of eyelid debris, including scurfs, collarettes, and demodex mites, using blinded assessment methods. Total participation lasts about one month with two follow-up visits, each lasting no more than 15 minutes, to monitor treatment effects and collect data for comparison between the two groups.

Evaluation of SUMMIT BRUSH in Treatment of Blepharitis